Clinical Trial Update: MEK and Autophagy Inhibition in Metastatic/Locally Advanced, Unresectable Neuroblastoma RAS (NRAS) Melanoma [NA]

View source ↗

Summary

A completed clinical trial update evaluating MEK inhibition with autophagy inhibition in metastatic NRAS-mutant melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nras-mutant Melanoma

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Metastatic NRAS Melanoma | NA | Status: COMPLETED